BioMarin Clinical Trial Program Update for Duchenne Muscular Dystrophy

April 23, 2024

On Tuesday, April 23, 2024, BioMarin Pharmaceuticals shared a Clinical Trial program update for the Duchenne community, including what they have been working on and a breakdown of study details.

View their community update by clicking here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open